Sukenaga Y - Search Results

1

Identification of SARS-CoV-2 M^pro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Higashi-Kuwata N, Tsuji K, Hayashi H, Bulut H, Kiso M, Imai M, Ogata-Aoki H, Ishii T, Kobayakawa T, Nakano K, Takamune N, Kishimoto N, Hattori SI, Das D, Uemura Y, Shimizu Y, Aoki M, Hasegawa K, Suzuki S, Nishiyama A, Saruwatari J, Shimizu Y, Sukenaga Y, Takamatsu Y, Tsuchiya K, Maeda K, Yoshimura K, Iida S, Ozono S, Suzuki T, Okamura T, Misumi S, Kawaoka Y, Tamamura H, Mitsuya H. Higashi-Kuwata N, et al. Among authors: sukenaga y. Nat Commun. 2023 Feb 25;14(1):1076. doi: 10.1038/s41467-023-36729-0. Nat Commun. 2023. PMID: 36841831 Free PMC article.

2

4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.

Takamatsu Y, Tanaka Y, Kohgo S, Murakami S, Singh K, Das D, Venzon DJ, Amano M, Higashi-Kuwata N, Aoki M, Delino NS, Hayashi S, Takahashi S, Sukenaga Y, Haraguchi K, Sarafianos SG, Maeda K, Mitsuya H. Takamatsu Y, et al. Among authors: sukenaga y. Hepatology. 2015 Oct;62(4):1024-36. doi: 10.1002/hep.27962. Epub 2015 Aug 25. Hepatology. 2015. PMID: 26122273 Free PMC article.

3

Lysocellin, a metabolite of the novel drug 'alopestatin', induces G1 arrest and prevents cytotoxicity induced by etoposide.

Takahara Y, Yogosawa S, Maruyama S, Watanabe N, Yokoyama H, Fukasawa K, Sukenaga Y, Kamiyama J, Izumi M, Wakada M, Zhang H, Yoshizawa K, Kawa S, Nikaido T, Sakai T. Takahara Y, et al. Among authors: sukenaga y. Int J Oncol. 2006 Apr;28(4):823-9. Int J Oncol. 2006. PMID: 16525630

4

Impact of chymase inhibitor on cardiac function and survival after myocardial infarction.

Jin D, Takai S, Yamada M, Sakaguchi M, Kamoshita K, Ishida K, Sukenaga Y, Miyazaki M. Jin D, et al. Among authors: sukenaga y. Cardiovasc Res. 2003 Nov 1;60(2):413-20. doi: 10.1016/s0008-6363(03)00535-2. Cardiovasc Res. 2003. PMID: 14613871

5

A novel chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[,4-dioxo-1-phenyl-7-(2-pyridyloxy)]2-heptyl]acetamide (NK3201), suppressed intimal hyperplasia after balloon injury.

Takai S, Sakonjo H, Fukuda K, Jin D, Sakaguchi M, Kamoshita K, Ishida K, Sukenaga Y, Miyazaki M. Takai S, et al. Among authors: sukenaga y. J Pharmacol Exp Ther. 2003 Feb;304(2):841-4. doi: 10.1124/jpet.102.042580. J Pharmacol Exp Ther. 2003. PMID: 12538841

6

Development of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities.

Sukenaga Y, Kamoshita K, Takai S, Miyazaki M. Sukenaga Y, et al. Jpn J Pharmacol. 2002 Nov;90(3):218-22. doi: 10.1254/jjp.90.218. Jpn J Pharmacol. 2002. PMID: 12499575 Free article. Review.

7

Oxidative modification of NK30424A and B enhance inhibitory effect on lipopolysaccharide-induced tumour necrosis factor-alpha promoter activity.

Takayasu Y, Tsuchiya K, Sukenaga Y. Takayasu Y, et al. Among authors: sukenaga y. J Antibiot (Tokyo). 2002 Mar;55(3):337-40. doi: 10.7164/antibiotics.55.337. J Antibiot (Tokyo). 2002. PMID: 12014450 Free article. No abstract available.

8

NK30424A and B, novel inhibitors of lipopolysaccharide-induced tumour necrosis factor alpha production, produced by Streptomyces sp. NA30424.

Takayasu Y, Tsuchiya K, Aoyama T, Sukenaga Y. Takayasu Y, et al. Among authors: sukenaga y. J Antibiot (Tokyo). 2001 Dec;54(12):1111-5. doi: 10.7164/antibiotics.54.1111. J Antibiot (Tokyo). 2001. PMID: 11858670 Free article. No abstract available.

9

Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.

Takai S, Jin D, Nishimoto M, Yuda A, Sakaguchi M, Kamoshita K, Ishida K, Sukenaga Y, Sasaki S, Miyazaki M. Takai S, et al. Among authors: sukenaga y. Life Sci. 2001 Aug 31;69(15):1725-32. doi: 10.1016/s0024-3205(01)01255-3. Life Sci. 2001. PMID: 11665834

10

N-linked oligosaccharide processing enzyme glucosidase II produces 1,5-anhydrofructose as a side product.

Hirano K, Ziak M, Kamoshita K, Sukenaga Y, Kametani S, Shiga Y, Roth J, Akanuma H. Hirano K, et al. Among authors: sukenaga y. Glycobiology. 2000 Dec;10(12):1283-9. doi: 10.1093/glycob/10.12.1283. Glycobiology. 2000. PMID: 11159920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page